Company profile: Trinean
1.1 - Company Overview
Company description
- Provider of micro-volume molecular spectroscopy solutions, combining best-in-class analytical software with a highly standardized read-out platform; commercializes UV/VIS spectrometers.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Trinean
List Labs
HQ: United States
Website
- Description: Provider of microbial CDMO services, offering end-to-end support from early-stage process development to cGMP manufacturing for Phase I & II clinical supply, and research reagents including nearly 100 bacterial toxins, polysaccharides, and antibodies. Also supplies anthrax (PA, EF, LF), botulinum, C. difficile (Toxin A/B), and cholera toxins, and specializes in native toxins, recombinant proteins, fermentation, and assay development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full List Labs company profile →
Nabsys
HQ: United States
Website
- Description: Provider of semiconductor-based tools for genomic analysis leveraging solid-state, single-molecule positional sequencing and electronic high-definition mapping to analyze entire genomes and structural variants. Offerings include the OhmX Analyzer, Human Chromosome Explorer software, OhmX Sample Prep Kit, OhmX-8 Detector, OhmX Cartridges, and electronic genome mapping via solid-state nanodetectors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nabsys company profile →
Proteos
HQ: United States
Website
- Description: Provider of contract research services specializing in recombinant protein expression and purification to support drug discovery in the biotechnology and pharmaceutical industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Proteos company profile →
BioDtech
HQ: United States
Website
- Description: Provider of reagents and systems for the detection, neutralization, and removal of endotoxin for researchers in bioresearch and bioprocess markets, offering detection solutions including EndoDtec-F to uncover bacteria in environmental samples, injectable drugs, and medical devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioDtech company profile →
Nektar Therapeutics
HQ: United States
Website
- Description: Provider of therapeutics based on an advanced polymer conjugate chemistry platform, including Rezpegaldesleukin (REZPEG/NKTR-358), a regulatory T cell stimulator targeting the IL-2 receptor complex to address immune imbalances in autoimmune and inflammatory diseases; PEG-CSF Protein to modulate inflammation resolution; and a bivalent TNFR antibody that selectively stimulates TNFR2 to enhance T regulatory cell function.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nektar Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Trinean
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Trinean
2.2 - Growth funds investing in similar companies to Trinean
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Trinean
4.2 - Public trading comparable groups for Trinean
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →